ConductScience.org, home

Paper656270

Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

Bateson MC and 3 others. Br J Clin Pharmacol, 1978. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Papers, record 656270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/656270

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bateson MCM C
2Maclean DD
3Evans JRJ R
4Bouchier IAI A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chenodeoxycholic AcidMajor topic
HyperlipidemiasMajor topic
TriglyceridesMajor topic
Adult
Aged
Cholesterol
Clofibrate
Humans
Liver Function Tests
Male
Middle Aged

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114262568A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.Circulation1965https://conductscience.org/library/papers/14262568PubMed
25381845Clinical evaluation of a new hypolipidemic drug, CIBA 13,437-Su.J Atheroscler Res1969https://conductscience.org/library/papers/5381845PubMed
35539274Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.Ann Intern Med1971https://conductscience.org/library/papers/5539274PubMed
44138590Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia.Lancet1974https://conductscience.org/library/papers/4138590PubMed
54152191Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid.Gut1974https://conductscience.org/library/papers/4152191PubMed
64111826Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.Lancet1972https://conductscience.org/library/papers/4111826PubMed
74363888Treatment of hyperlipidemia.N Engl J Med1974https://conductscience.org/library/papers/4363888PubMed
84345943Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet.Am J Med1971https://conductscience.org/library/papers/4345943PubMed
947547Potential effect on coronary-heart-disease morbidity of lowering the blood-cholesterol.Lancet1975https://conductscience.org/library/papers/47547PubMed
104851965Experience with simplified scheme of treatment of hyperlipidaemia.Br Med J1974https://conductscience.org/library/papers/4851965PubMed
114817832Effect of bile acid feeding on cholesterol metabolism in gallstone patients.Mayo Clin Proc1974https://conductscience.org/library/papers/4817832PubMed
124741607Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy.Br Med J1973https://conductscience.org/library/papers/4741607PubMed
134718952Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.J Clin Invest1973https://conductscience.org/library/papers/4718952PubMed
144681896Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet.N Engl J Med1973https://conductscience.org/library/papers/4681896PubMed
155041275Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.J Lipid Res1972https://conductscience.org/library/papers/5041275PubMed
164930042Classification of hyperlipidaemias and hyperlipoproteinaemias.Bull World Health Organ1970https://conductscience.org/library/papers/4930042PubMed
17955328The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.Digestion1976https://conductscience.org/library/papers/955328PubMed
181224909[The treatment of cholelithiasis by chenic acid. Present state of a prospective study (author's transl)].Acta Gastroenterol Belg1975https://conductscience.org/library/papers/1224909PubMed
194818152Prevalence of hyperlipoproteinaemia in apparently healthy men.Br Heart J1974https://conductscience.org/library/papers/4818152PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42405097Amide-functionalized cholic acid hybrids: design, bioactivity, and computational analysis.RSC Adv2026https://conductscience.org/library/papers/42405097PubMed
36574136Lactiplantibacillus plantarum PGB02 Improved Serum Cholesterol Profile by Tweaking Genes Involved in Cholesterol Homeostasis in Male Swiss Albino Mice.Appl Biochem Biotechnol2023https://conductscience.org/library/papers/36574136PubMed
36263401Dietary supplementation of porcine bile acids improves laying performance, serum lipid metabolism and cecal microbiota in late-phase laying hens.Anim Nutr2022https://conductscience.org/library/papers/36263401PubMed
35495722Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice.Front Microbiol2022https://conductscience.org/library/papers/35495722PubMed
34950217Study on the Mechanism of Reducing Hepatotoxicity of Water-Grinding Realgar by Metabolomics, Morphology, and Chemical Analysis.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34950217PubMed
30936623Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model.J Clin Biochem Nutr2019https://conductscience.org/library/papers/30936623PubMed
29409713Bilirubin in the Liver-Gut Signaling Axis.Trends Endocrinol Metab2018https://conductscience.org/library/papers/29409713PubMed
25500875Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.Acta Pharmacol Sin2015https://conductscience.org/library/papers/25500875PubMed
25214402Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model.Am J Physiol Gastrointest Liver Physiol2014https://conductscience.org/library/papers/25214402PubMed
23988487Bile acid receptors in non-alcoholic fatty liver disease.Biochem Pharmacol2013https://conductscience.org/library/papers/23988487PubMed
23447519Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.Eur J Endocrinol2013https://conductscience.org/library/papers/23447519PubMed
22550135Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.J Lipid Res2012https://conductscience.org/library/papers/22550135PubMed
21991404Bile Acid signaling in liver metabolism and diseases.J Lipids2012https://conductscience.org/library/papers/21991404PubMed
21431855Bile acid metabolism and the pathogenesis of type 2 diabetes.Curr Diab Rep2011https://conductscience.org/library/papers/21431855PubMed
21383957Deciphering the nuclear bile acid receptor FXR paradigm.Nucl Recept Signal2010https://conductscience.org/library/papers/21383957PubMed
20949026The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice.PLoS One2010https://conductscience.org/library/papers/20949026PubMed
20463294Pathogenesis of alcoholic liver disease: the role of nuclear receptors.Exp Biol Med (Maywood)2010https://conductscience.org/library/papers/20463294PubMed
20373033Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase.Mol Biol Rep2011https://conductscience.org/library/papers/20373033PubMed
20041971FXR an emerging therapeutic target for the treatment of atherosclerosis.J Cell Mol Med2010https://conductscience.org/library/papers/20041971PubMed
15146238Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.J Clin Invest2004https://conductscience.org/library/papers/15146238PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/656270

GET https://conductscience.org/api/papers/v1/656270/cited_by?page=2